History Says Coca-Cola Stock Holds Up When the S&P 500 Falls

Coca-Cola shares are up about 23% year to date to roughly $86 and trade near 26x earnings, leaving limited valuation cushion despite historically resilient performance in market downturns. The company grew adjusted EPS 11% in Q2 2026 after 18% growth in Q1 and raised its full-year adjusted EPS growth outlook to 9%-10% from 8%-9%. Coca-Cola outperformed the S&P 500 in seven of eight negative-index calendar years since 1980, but it still suffered total-return losses of about 21% in 2001, 5.5% in 2002, and 24% in 2008; the article views the stock as sensible to hold but unattractive for new purchases at current levels.

Analysis

KO is increasingly functioning as a low-beta equity-duration substitute rather than a pure staples exposure. At roughly 26x current earnings, the valuation leaves little room for the normal deceleration from unusually strong recent EPS growth; even a modest reset toward 22-23x would create a 12-15% downside before dividends. The key issue is not whether volumes prove defensive in a recession, but whether investors continue to pay an above-market multiple when risk-free rates, USD moves, or input-cost inflation challenge the “safe compounder” narrative.

The second-order beneficiary of a rotation into staples is likely PEP, which offers similar defensive demand but a more credible self-help path through portfolio simplification and food-margin recovery. KO is relatively more exposed to FX translation and emerging-market affordability, while PEP has greater exposure to pressured North American snacks; the appropriate expression depends on whether the macro shock is disinflationary/growth-led (favor PEP) or commodity/inflation-led (favor KO). Bottlers and packaging suppliers would not receive proportional upside from a KO multiple re-rating, since concentrate pricing and franchise economics concentrate incremental value at KO.

Over the next 1-3 months, the relevant catalyst is whether organic volume and price/mix remain balanced in the next earnings update; defensive investors will tolerate premium valuation only if growth is not exclusively price-led. Over 6-18 months, a stronger dollar, weaker emerging-market consumption, or sustained sugar/aluminum/PET inflation can expose limits to pricing power and compress both earnings expectations and the multiple. The defensive thesis is falsified less by an equity-market drawdown than by a guidance cut, a material volume miss, or forward EPS estimates falling below the level needed to support a mid-20s P/E.

Contrarian view: consensus may be overpaying for historical drawdown resilience precisely after the stock has become a crowded hedge. KO can outperform in a selloff yet still generate negative absolute returns; therefore it is a poor standalone downside hedge at current valuation versus Treasury duration or index puts. There is no high-conviction directional trade absent evidence of weakening estimates, but relative-value positioning is attractive if staples leadership persists.

Key Decisions for Investors

• Avoid initiating outright KO longs at current valuation; use a pullback toward 22-23x forward EPS, or approximately 10-15% below current levels absent an upward earnings revision, as the preferred entry zone.
• For a 3-6 month defensive-equity allocation, consider long PEP / short KO in equal dollar amounts. Target 8-12% relative upside if PEP’s margin recovery and valuation discount close; exit if KO raises full-year organic-growth guidance or PEP’s North American food volumes deteriorate further.
• For existing KO exposure, retain only as a beta-reduction sleeve and cap position size; hedge broad-equity downside separately with 3-6 month SPY puts rather than assuming KO protects absolute capital in a sharp de-risking event.
• Set an earnings watch on volume versus price/mix and forward EPS revisions: reduce KO on a volume miss combined with unchanged pricing, or if consensus 2027 EPS falls enough that the forward multiple remains above 25x. Conversely, suspend the short bias if organic volume accelerates while FX and commodity inputs remain benign.